Evidence map›Paper›PMID 36474811›Full record

ArticleOsteoarthritis and cartilage open2021

Study protocol for the follow-up examination of the Nor-Hand study: A hospital-based observational cohort study exploring pain and biomarkers in people with hand osteoarthritis.

Marthe Gløersen, Pernille Steen Pettersen, Øystein Maugesten, Elisabeth Mulrooney, Alexander Mathiessen, Heidi Gammelsrud, Hilde Berner Hammer, Tuhina Neogi, Sarah Ohrndorf, Karwan Faraj and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Osteoarthritis and cartilage open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Marthe GløersenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Pernille Steen PettersenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Øystein MaugestenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Elisabeth MulrooneyDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Alexander MathiessenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Heidi GammelsrudDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Hilde Berner HammerDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Tuhina NeogiSection of Rheumatology, Boston University School of Medicine, Boston, United States.
Sarah OhrndorfDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Karwan FarajDepartment of Radiology, Diakonhjemmet Hospital, Oslo, Norway.
Dag SjølieDepartment of Radiology, Diakonhjemmet Hospital, Oslo, Norway.
Barbara Slatkowsky-ChristensenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Tore Kristian KvienDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Ida Kristin HaugenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Diakonhjemmet Hospital · NOUniversity of Oslo · NOBoston University · USCharité - Universitätsmedizin Berlin · DE

Funding

Research and Evaluation Support Core Unit (RESCU Core)P30AR072571 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Michael Paul Lavalley · 2019 to 2026
$6.9M
NIAMS NIH HHS P30 AR072571
6 · The paper itself

Abstract

Objective: This study aims to increase the understanding of pain mechanisms in hand OA and explore potential risk factors for pain development or worsening in a biopsychosocial framework. Another important aim is to validate potential soluble and imaging OA biomarkers. Design: The follow-up examination of the Nor-Hand hospital-based observational cohort study started in October 2019 and was completed in May 2021. In total, 212 of the 300 participants with hand OA who were examined at baseline attended the follow-up study. The participants underwent clinical joint examinations, medical and functional assessments, quantitative sensory testing, fluorescence optical imaging, ultrasound of the hands, acromioclavicular joints, feet, knees and hips, conventional radiographs of the hands and feet and magnetic resonance imaging of the dominant hand. Blood and urine samples were collected, and all participants answered questions about demographic factors and OA-related questionnaires. Associations between disease variables and symptoms will be examined in cross-sectional and longitudinal analyses. Longitudinal analyses will be performed to assess the predictive value of baseline variables on hand OA outcomes. Conclusion: Current knowledge about predictors for disease progression in hand OA is limited, but with longitudinal data we will be able to explore the predictive value of baseline variables on hand OA outcomes, such as changes in patient-reported outcomes or changes in soluble and imaging biomarkers. This provides a unique opportunity to gain more knowledge about the natural disease course of hand OA.

Indexed as

Hand osteoarthritisImagingOutcome measuresPain

Identifiers

PMID36474811
PMCPMC9718069
OpenAlexW3191873449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.